Vyne, a London-based real-time account-to-account payments platform, has announced that it will be winding down its UK operations effective April 22. This decision comes just months after Vyne was ...

VYNE Therapeutics (VYNE – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Joseph Pantginis from H.C. Wainwright maintained a Buy rating on ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Patrick G. LePore, a director at VYNE Therapeutics Inc. (NASDAQ:VYNE), recently acquired 15,000 shares of the company's common stock. The transaction, which took place on January 15, 2025 ...

06, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to ...

The VYN201 gel is intended to treat non-segmental vitiligo. Credit: Prostock-studio / Shutterstock. US-based pharmaceutical company VYNE Therapeutics has completed enrolment in the randomised Phase ...

This content has been selected, created and edited by the Finextra editorial team based upon its relevance and interest to our community. In a statement on its website, Vyne says it will "cease ...